BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 8843175)

  • 61. Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog.
    Connolly CC; Adkins-Marshall BA; Neal DW; Pugh W; Jaspan JB; Cherrington AD
    Diabetes; 1992 Oct; 41(10):1308-19. PubMed ID: 1397705
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Subclinical ammonia toxicity in steers: effects on blood metabolite and regulatory hormone concentrations.
    Fernandez JM; Croom WJ; Johnson AD; Jaquette RD; Edens FW
    J Anim Sci; 1988 Dec; 66(12):3259-66. PubMed ID: 3068222
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Paradoxical insulin-induced increase in gluconeogenesis in response to prolonged hypoglycemia in conscious dogs.
    Davis SN; Dobbins R; Tarumi C; Jacobs J; Neal D; Cherrington AD
    Am J Physiol; 1995 Mar; 268(3 Pt 1):E521-30. PubMed ID: 7900798
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of insulin infusion on plasma catecholamine concentration in fetal sheep.
    Stonestreet BS; Piasecki GJ; Susa JB; Jackson BT
    Am J Obstet Gynecol; 1989 Mar; 160(3):740-5. PubMed ID: 2648843
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reduced epinephrine clearance and glycemic sensitivity to epinephrine in older individuals.
    Marker JC; Clutter WE; Cryer PE
    Am J Physiol; 1998 Nov; 275(5):E770-6. PubMed ID: 9814995
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic effects of dobutamine in normal man.
    Green CJ; Frazer RS; Underhill S; Maycock P; Fairhurst JA; Campbell IT
    Clin Sci (Lond); 1992 Jan; 82(1):77-83. PubMed ID: 1310921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat.
    Bieberdorf FA; Chernick SS; Scow RO
    J Clin Invest; 1970 Sep; 49(9):1685-93. PubMed ID: 5452413
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Blood flow and nutrient exchange across the liver and gut of the dairy cow. Effects of lactation and fasting.
    Lomax MA; Baird GD
    Br J Nutr; 1983 May; 49(3):481-96. PubMed ID: 6860627
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.
    Cryer PE; Rizza RA; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1114-8. PubMed ID: 6107816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of hepatic portal glucose concentration on food intake and metabolism.
    Tordoff MG; Tluczek JP; Friedman MI
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1474-80. PubMed ID: 2690650
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of inducing physiological hyperglucagonemia on metabolic responses to exercise.
    Bélanger P; Fillion Y; Couturier K; Gauthier MS; Lavoie JM
    Eur J Appl Physiol; 2003 Mar; 89(1):8-13. PubMed ID: 12627299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Portal adrenergic blockade does not inhibit the gluconeogenic effects of circulating catecholamines on the liver.
    Chu CA; Sindelar DK; Neal DW; Cherrington AD
    Metabolism; 1997 Apr; 46(4):458-65. PubMed ID: 9109855
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension.
    Grekin RJ; Vollmer AP; Sider RS
    Hypertension; 1995 Jul; 26(1):193-8. PubMed ID: 7607723
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic, pulmonary and mesenteric perfusion and oxygenation effects of dopamine and epinephrine.
    Cheung PY; Barrington KJ; Pearson RJ; Bigam DL; Finer NN; Van Aerde JE
    Am J Respir Crit Care Med; 1997 Jan; 155(1):32-7. PubMed ID: 9001285
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humans.
    Keller U; Weiss M; Stauffacher W
    Diabetes; 1989 Apr; 38(4):454-9. PubMed ID: 2538376
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs.
    el-Tayeb KM; Vranic M; Brubaker PL; Lickley HL
    Diabetologia; 1987 Sep; 30(9):745-54. PubMed ID: 2962893
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The metabolic response to norepinephrine in normal versus diabetic man.
    Schade DS; Eaton RP
    Diabetologia; 1978 Dec; 15(6):433-9. PubMed ID: 720776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.